We are live on
!
Find out more
VV
Verity & Verity Portfolio holdings
AUM
$1.34B
1-Year Est. Return
18.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.93%
1 Year Est. Return
+18.66%
3 Year Est. Return
+55.97%
5 Year Est. Return
+76.97%
10 Year Est. Return
+236.01%
AUM
$1.25B
AUM Growth
+$86.1M
(+7.4%)
Cap. Flow
+$18.3M
Cap. Flow
% of AUM
1.47%
Top 10 Holdings %
Top 10 Hldgs %
30.64%
Holding
139
New
6
Increased
58
Reduced
51
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$22.4M |
| 2 |
Accenture
ACN
|
+$14.9M |
| 3 |
Canadian National Railway
CNI
|
+$5.93M |
| 4 |
Prologis
PLD
|
+$5.45M |
| 5 |
Polen Dividend Income ETF
DIVZ
|
+$4.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Pharmaceutical ETF
PPH
|
+$11.6M |
| 2 |
Truist Financial
TFC
|
+$10M |
| 3 |
Hershey
HSY
|
+$9.31M |
| 4 |
OGE Energy
OGE
|
+$8.97M |
| 5 |
Blue Owl Capital
OWL
|
+$4.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.35% |
| 2 | Financials | 17.35% |
| 3 | Healthcare | 14.67% |
| 4 | Energy | 10.71% |
| 5 | Industrials | 8.35% |
Similar funds
HAM
PO
OCMI
FFW
VHAM
CA
NEWAS
BFMH
Verity & Verity's Q3 2025 Portfolio in Review
As of Q3 2025, Verity & Verity held 139 positions worth $1.25B, up 7.4% from $1.16B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Verity & Verity's Q3 2025 filing shows 6 new, 58 increased, 51 reduced and 5 closed positions. Its largest new stake was Polen Dividend Income ETF: 136,886 shares worth $4.98M. The largest sale was VanEck Pharmaceutical ETF, an estimated $11.6M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Verity & Verity's largest Q3 2025 buy was Polen Dividend Income ETF: 136,886 shares worth $4.98M.
- Verity & Verity added most to Pfizer in Q3 2025, an estimated $22.4M increase.
- Verity & Verity's biggest Q3 2025 reduction was Truist Financial, cutting an estimated $10M.
- Verity & Verity fully exited VanEck Pharmaceutical ETF in Q3 2025, selling an estimated $11.6M.
- Verity & Verity's ten largest holdings make up 31% of its $1.25B portfolio in Q3 2025.
- Verity & Verity opened 6 new positions and closed 5 in Q3 2025.
- Verity & Verity's portfolio value rose 7.4% quarter-over-quarter to $1.25B.
Based on Verity & Verity's 13F filing for Q3 2025, filed 21 Oct 2025.